PALISADE BIO, INC. — Director's Dealing 2015

May 21, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-05-18

Reporting Person: LLOYD JONES JONATHAN BRIAN (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Purchase Option	$1.71	2025-05-18	Common Stock (50000)		Direct

Footnotes

F1: Represents options granted under the company's 2010 equity compensation plan pursuant to the Reporting Person's employment.

F2: The options vest quarterly over two years, commencing on 5/18/2015 (the grant date).